Pharmaceutical Associates
As of the edition of 20 October 2026, Pharmaceutical Associates runs 7 drugs, 7 of them marketed.
Sources: ClinicalTrials.gov, FDA Orange Book and Purple Book, other approval registers, company records.
Drugs by status
| Status | Count |
|---|---|
| Marketed | 7 |
| Total | 7 |
Marketed drugs and when their US protection ends
| Drug | US protection | Route B rows |
|---|---|---|
| Ceftazidime | none listed | 0 |
| Ranitidine | none listed | 1 |
| Cefuroxime | none listed | 0 |
| Phytonadione | none listed | 0 |
| Orphenadrine | none listed | 2 |
| Cefotetan | none listed | 0 |
| Edrophonium | none listed | 0 |
A route B row is one company at one target.